BridgeBio Pharma (BBIO) Earnings Analysis
BridgeBio Pharma (BBIO) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it missed with EPS -0.84 USD vs -0.67877 USD est (-23.8%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E -22.04.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BBIO next report earnings?
No confirmed upcoming earnings date is currently scheduled for BBIO. This page updates as the calendar is published.
BBIO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.84 USD | -0.67877 USD | -23.8% | Miss |
| 2025-10-29 | -0.95 USD | -0.88 USD | -8% | Miss |
| 2025-02-20 | -1.31 USD | -1.09 USD | -20.2% | Miss |
| 2024-08-01 | -1.02 USD | -1.09 USD | +6.4% | Beat |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
BBIO valuation and analyst view
| Trailing P/E | -22.04 |
|---|---|
| Trailing EPS | -3.72672 USD |
| Price / book | -7.10 |
| Dividend yield | 0.00% |
| Market cap | 16.09B |
| Analyst consensus | Buy (23 buy / 3 hold / 0 sell) |
| Avg price target | 109.25 USD |
Related research pages
Frequently asked questions
When is BridgeBio Pharma (BBIO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for BBIO. This page updates as the calendar is published.
Did BBIO beat earnings last quarter?
In its 2026-05-07 report, BBIO posted EPS of -0.84 USD versus a -0.67877 USD estimate — a miss of 23.8%.
What is BBIO's earnings track record?
Over the last 4 reported quarters with consensus data, BBIO beat estimates 1 times (25%).
What is BBIO's current P/E ratio and EPS?
BBIO trades at a trailing P/E of -22.04 on trailing EPS of -3.726717921104502 USD.
What do analysts rate BBIO?
Analyst consensus is "Buy" across 26 ratings (0 strong buy, 23 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 109.25 USD.